O qué e OLYSIO?

Rate this item
(0 votes)

 

olysioOLYSIO TM

(simeprevir) has been approved by the FDA in late 2013 and is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) mas Olysio

 

Read 784 times Last modified on sexta, 24 julho 2015 13:08










Confira